Clinical Trial: Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease

Brief Summary: This study will test to see if metformin is safe and if it is tolerated compared to placebo in adult Autosomal Dominant Polycystic Kidney Disease (ADPKD) patients with beginning stages of chronic kidney disease. We will also measure its effect on progression of kidney disease as reflected in the kidney size and the kidney function, along with its effect on kidney pain and quality of life.